Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01024101 |
|
Recruitment Status :
Completed
First Posted : December 2, 2009
Last Update Posted : April 25, 2011
|
Sponsor:
Bristol-Myers Squibb
Information provided by:
Bristol-Myers Squibb
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2005 |
| Actual Study Completion Date : | December 2005 |
| Certification/Extension First Submitted : | February 2, 2010 |